South African Medical News

Back to Home Page

Print using browser
Waxsol, docusate sodium BP (Meda)


Dear Healthcare Professional

Meda Pharma South Africa wish to advise that certain batches of Waxsol are being recalled as a precautionary measure with immediate effect.

This recall is classified as a Class II, Type B, as agreed with the South African Health Products Regulatory Authority (SAHPRA).

Should you have any queries, please contact:
Mylan Customer Care Centre
Tel: +27 76 6898484 or +27 (0) 11 451 1325.
  • This is a drug - read the leaflet carefully before use 
  • Ask your doctor or pharmacist for further information.
This recall is due to an out of speculation result obtained during stability testing.

A medical risk assessment has been completed and concludes that there is no risk to patient.

Please immediately quarantine any units of the mentioned batches(s) that you have in your possession and return to your supplier, wholesaler or distributor for full credit.


MEDA would like to reinforce their commitment to reliability in supply and they apologise for any inconvenience caused.

For full prescribing information refer to the package insert approved by the medicines regulatory authority.

Meda Pharma South Africa (Pty) Ltd, Building 6, Greenstone Hill Office Park, Emerald Boulevard, Modderfontein.

You need to be logged in to see more details. Register Now!

Click here to visit the MEDA website.....
Contact: Shaistha Sing, Responsible Pharmacist
Telephone: +27 (0) 11 451 1300
Date: Thursday, January 31, 2019